P&G: Contracting saves the day - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

P&G: Contracting saves the day

Oct 27, 2004

Performance summary
P&G Hygiene and Healthcare (P&G) has reported an 11% growth in September quarter revenues (its first quarter for the current year), and over 34% bottomline growth. Though the revenue performance is encouraging, it pales in comparison to FY04, where the company had clocked over 30% growth during the year. The company earned an exceptional income to the tune of Rs 64 m as profit on sale of fixed assets during the quarter. Excluding this, profits before tax still grew by an encouraging 17% YoY.

(Rs m)1QFY041QFY05ChangeFY04YoY Change
Net sales and licence fees1,2851,42110.6%5,77230.5%
Operating profit (EBDITA)30636720.1%1,25437.1%
EBDITA margin (%)23.8%25.8% 21.7% 
Other income4034-14.7%1501.5%
Interest 00-4-27.3%
Profit before Tax32037517.3%1,27237.3%
Tax99143 44.5%350 42.2%
Extraordinary income/(expense) - 64 - - -
Profit after tax/(loss)22129634.3%92235.5%
Net profit margin (%)17.2%20.8% 16.0% 
No. of shares (m)21.632.5 32.5 
Diluted earnings per share (Rs)*27.236.5 28.4 
Price to earnings ratio (x) 13.0   

What is the company’s business?
P&G is a 65% subsidiary of the FMCG major, P&G USA. In India, the company is a focused two-product company, dominating both segments backed by strong brands, namely ‘Vicks’ in the anti-cold segment and ‘Whisper’ in feminine care segment. The parent has two other 100% subsidiaries in India which have a dominant shampoo and detergent portfolio. P&G undertakes contract manufacturing for its parent's detergent portfolio (Ariel, Tide) in India.

What has driven performance in 1QFY05?
Core blues:  The company's key businesses, anti cold (Vicks range) and feminine care (Whisper) underperformed during the quarter. While this business grew by 18% in FY04 (June ending), it has seen a dip of 3% in the September quarter. The company has attributed this staid performance in core categories to temporary supply constraints during the quarter caused by trucker’s strike and packaging related sourcing issues. As per the company's release, the latest AC Nielsen - ORG data indicates significant pick up in value market share on both Whisper (up 5% YoY) and Vicks (up 10% YoY).

Contract manufacturing supports topline:  The key growth driver for the company's topline continued to be the detergent contract manufacturing business. This division saw a significant 46% growth in revenues. The parent's strategy to garner a bigger chunk of the Indian detergent market by slashing product prices to almost half, has done wonders for this division. It is safe to conclude from the numbers available that the parent has seen a surge in offtake as a result of these price cuts. P&G too has benefited in terms of higher volume of contract manufacturing. Consequently, the division's contribution to overall revenues has gone up from 28% in 1QFY04 to nearly 37% in 1QFY05.

Segment snapshot
(Rs m)1QFY041QFY05ChangeFY04YoY Change
Health and hygiene products928902-2.9%3,72318.0%
% of revenues72.3%63.5% 64.5% 
PBIT margin (%)30.0%35.6% 28.8% 
Contract manufacturing35651945.8%2,05061.4%
% of revenues27.7%36.5% 35.5% 
PBIT margin (%)4.7%4.1% 5.1% 
Total segment revenue1,2851,42110.6%5,77230.5%
Total PBIT margin (%)23.0%24.1% 20.4% 

Margin mix:  Though the core business performance was relatively staid on the revenue front, its profitability improved significantly during the quarter. PBIT margins of this business went up by nearly 6% during the quarter, thereby strengthening the company's overall operating profit margins. On the other hand, though contract manufacturing put in a strong revenue performance, the business' PBIT margins dipped marginally to 4.1%. The focus on improving efficiencies, as well as the restructuring of employees has helped the company cut costs as a percentage of sales. In 1QFY05, raw material and packaging costs have seen a significant surge. This seems a result of higher volume of contract manufacturing.

Cost break-up
as a % to sales1QFY041QFY05FY04
Consumption of raw and packaging material30.7%43.9%40.0%
Purchase of trading material9.6%1.7%5.8%
Staff cost8.5%6.9%6.4%
Advertising expenses7.6%8.4%197.9%
Other expenditure19.8%13.3%17.2%
Total expenditure76.2%74.2%78.3%

Over the last five quarters
The company's topline momentum really came in from the March quarter. This was the period when the parent declared a price war in the detergent segment. Operating margins have remained inconsistent during the past five quarters and have shown signs of pressure, ever since the contract manufacturing business has picked up. The reason being that the margins of this business are very meager at around 5%, as compared to nearly 29% in its health and hygiene business. With detergent prices still ruling low, we believe that contract manufacturing fillip will continue. But that could have a bearing on the margins.

Sales growth (YoY)20.6%18.3%40.5%51.4%10.6%
OPM (%)23.8%31.9%20.3%9.5%25.8%
Net profit growth (YoY)13.0%11.2%22.7%N C*34.3%
*Not comparable

Our view
At the current price of Rs 475, the stock trades at a P/E of 13 times 1QFY05 annualised earnings and market cap. to sales of 2.7x. Investors need to consider that over 90% of P&G's total PBIT comes from its core business. Though contract manufacturing will continue to spearhead topline momentum, focus should be on the company's core operations of health and hygiene. The positive thing is that its core business continues to perform well. With the peak cold season coming up, sales growth for its Vicks range is likely to be stronger than seen in the September quarter. The company has introduced a new variant of Whisper at a lower price point in southern India. This may increase penetration of the product, thereby aiding volume growth.

Equitymaster requests your view! Post a comment on "P&G: Contracting saves the day". Click here!


More Views on News

P&G HYGIENE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

Here's an analysis of the annual report of P&G HYGIENE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of P&G HYGIENE. Also includes updates on the valuation of P&G HYGIENE.

Adani Wilmar IPO to Hit the Market Soon. Should you Apply? (Views On News)

Nov 29, 2021

The parent company of the brand Fortune is set to raise Rs 45 bn from the market.

What Happens if ITC Hives off ITC Infotech? (Views On News)

Nov 20, 2021

The cigarette to hotel conglomerate is reportedly mulling the demerger of its software business at a valuation of around Rs 250 bn.

What Sparked an 8% Rally in ITC Shares Today? (Views On News)

Sep 16, 2021

ITC did not participate in the rally after the second wave and continued to underperform its peers. Is this about to change?

HUL's Marketcap Tops Rs 6 Tn. Key Factors Driving the Stock (Views On News)

Aug 21, 2021

HUL became the fifth Indian company to achieve the milestone of a Rs 6-tn market capitalisation.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

5 Indian Companies Embracing Blockchain Technology (Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.


Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Dec 3, 2021 (Close)


  • Track your investment in P&G HYGIENE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks